Ignite Creation Date:
2025-12-24 @ 10:44 PM
Ignite Modification Date:
2025-12-29 @ 7:56 PM
Study NCT ID:
NCT02534935
Status:
COMPLETED
Last Update Posted:
2021-09-27
First Post:
2015-02-23
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Immunogenicity, Safety and Tolerability of a Neisseria Meningitidis Serogroup B Bivalent Recominant Lipoprotein 2086 Vaccine (Bivalent rLP2086) in Healthy Toddlers.
Sponsor:
Pfizer
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2015-08-31
Start Date Type:
ACTUAL
Primary Completion Date:
2017-08-21
Primary Completion Date Type:
ACTUAL
Completion Date:
2020-03-17
Completion Date Type:
ACTUAL
First Submit Date:
2015-02-23
First Submit QC Date:
None
Study First Post Date:
2015-08-28
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2018-02-19
Results First Submit QC Date:
None
Results First Post Date:
2018-04-17
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-08-30
Last Update Post Date:
2021-09-27
Last Update Post Date Type:
ACTUAL